跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
WINREVAIR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
WINREVAIR
Authorized
STANDARD
WINREVAIR
Merck Canada Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
056780c49983c505
Company
Merck Canada Inc
Type
Standard
Approval Details
Approval Id
056780c49983c505
Drug Approval Canada Name
WINREVAIR
Product Name
WINREVAIR
Status
Marketed
Status Date
2025-02-12
Original Market Date
2025-02-12
Din
02551314
Drug Class
Human
Dosage Form
Kit , Powder For Solution
Route Of Administration
Subcutaneous
Schedule
Prescription , Schedule D
Ahfs
48:92.00
Atc Original
C02KX06 SOTATERCEPT
Atc Name
c 02 kx 06
Aig Number
0166144001
Company Name
Merck Canada Inc
Company Address
16750 Route Transcanadienne, Kirkland, Quebec, Canada, H9H 4M7
Active Ingredients
SOTATERCEPT
60 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
056780c49983c505
Type
Standard
Back to Health Canada Approvals